Good afternoon :)
Expleo Solutions Ltd

Expleo Solutions Ltd

EXPLEOSOL Share Price

NSE
883.150.14% (+1.20)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹1,368 cr, stock is ranked 1,452

Stock is 3.06x as volatile as Nifty

EXPLEOSOL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹1,368 cr, stock is ranked 1,452

Stock is 3.06x as volatile as Nifty

EXPLEOSOL Performance & Key Metrics

EXPLEOSOL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
9.941.76
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
21.565.473.31%

EXPLEOSOL Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

EXPLEOSOL Company Profile

Expleo Solutions is an India-based holding company. The Company is engaged in providing software testing services.

Investor Presentation

View older View older 

Aug 14, 2026

PDF
View Older Presentations

EXPLEOSOL Similar Stocks (Peers)

Compare with peers Compare with peers 

EXPLEOSOL Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
39.25
39.25
1Y Return
29.66%
29.66%
Buy Reco %
100.00
100.00
PE Ratio
45.50
45.50
1Y Return
2.72%
2.72%
Buy Reco %
58.06
58.06
PE Ratio
27.76
27.76
1Y Return
23.79%
23.79%
Buy Reco %
40.74
40.74
PE Ratio
196.95
196.95
1Y Return
23.46%
23.46%
Buy Reco %
90.00
90.00
PE Ratio
32.39
32.39
1Y Return
43.02%
43.02%
Buy Reco %
41.67
41.67
Compare with Peers

EXPLEOSOL Sentiment Analysis

EXPLEOSOL Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

EXPLEOSOL Stock Summary · May 2026

Headline: Results showed currency‑helped top‑line growth but margin compression and strategic reinvestment, with management stressing AI adoption and disciplined cost control. Q4 total income was INR 2,989 million, up 14.8% year‑on‑year, and management guided FY27 operating EBITDA margin around the mid‑teens (about 15–16%). Management described a constructive but cautious tone, highlighting that rupee depreciation materially boosted revenue and mark‑to‑market other income while constant‑currency trends were modestly negative, and they emphasized embedding AI across client engagements even if it cannibalizes near‑term revenue to preserve long‑term relationships. They cited wage inflation and one‑time labor‑related costs as drivers of adjusted EBITDA margin compression and stressed operating‑expense discipline and reduced discretionary spend to protect margins. Commercially, they are shifting go‑to‑market toward new‑logo acquisition, expanding partner‑led initiatives, pursuing a targeted M&A pipeline with likely near‑term deal closure, and prioritizing regional market building in Egypt and capacity expansion in aerospace & defense. Near term, they reiterated the mid‑teens EBITDA margin target and warned guidance is sensitive to currency movements.

EXPLEOSOL Stock Growth Drivers
EXPLEOSOL Stock Growth Drivers
7
  • Strong recent financial performance and improved liquidity with disciplined capital allocation

    The company delivered a materially stronger Q4 FY'26 and FY'26 performance, with Q4 total income

  • Early‑mover AI strategy and capability build‑out

    The company has moved from pilot to platform, deploying the expleo.ai platform last year and

EXPLEOSOL Stock Challenges
EXPLEOSOL Stock Challenges
11
  • AI-driven revenue compression and cannibalization of legacy work

    AI adoption is already materially compressing deal economics: management reports that similar pieces of work

  • Limited ability to monetize AI productivity gains due to customer pricing pressure

    Market dynamics force most AI-driven savings to be passed back to clients, constraining the company's

EXPLEOSOL Forecast

EXPLEOSOL Forecasts

Price

Revenue

Earnings

EXPLEOSOL

EXPLEOSOL

Income

Balance Sheet

Cash Flow

EXPLEOSOL Income Statement

EXPLEOSOL Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue257.22254.36271.94260.44260.31266.59295.40289.74300.91298.48
Operating & Other expensessubtract221.19213.37216.98219.04215.79229.92235.99250.07243.54249.20
Depreciation/Amortizationsubtract9.099.369.5212.378.057.677.447.305.923.87
Interest & Other Itemssubtract0.760.680.970.730.940.640.600.420.571.16
Taxes & Other Itemssubtract10.497.058.988.5111.447.9311.639.829.2110.06
EPS10.1215.4022.8612.7515.5113.1625.6214.2626.8522.02

EXPLEOSOL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Aug 14PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 13PDF
Feb 3PDF
Nov 13PDF
Aug 14PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 22PDF
Feb 6PDF
Nov 14PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 26PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

EXPLEOSOL Stock Peers

EXPLEOSOL Past Performance & Peer Comparison

EXPLEOSOL Past Performance & Peer Comparison

Comparing 3 stocks from 
Information TechnologySoftware Services

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Expleo Solutions Ltd11.041.76
Oracle Financial Services Software Ltd39.2513.243.36%
Persistent Systems Ltd45.5010.830.74%
L&T Technology Services Ltd27.765.471.73%

EXPLEOSOL Stock Price Comparison

Compare EXPLEOSOL with any stock or ETF
Compare EXPLEOSOL with any stock or ETF
EXPLEOSOL
Loading...

EXPLEOSOL Holdings

EXPLEOSOL Shareholdings

EXPLEOSOL Promoter Holdings Trend

EXPLEOSOL Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

EXPLEOSOL Institutional Holdings Trend

EXPLEOSOL Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

EXPLEOSOL Shareholding Pattern

EXPLEOSOL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.05%0.00%0.12%0.13%28.70%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

EXPLEOSOL Shareholding History

EXPLEOSOL Shareholding History

MarJunSepDec '25MarJun0.33%0.10%0.13%0.32%0.42%0.13%

EXPLEOSOL Insider Trades & Bulk Stock Deals

EXPLEOSOL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing EXPLEOSOL stock

smallcases containing EXPLEOSOL stock

Looks like this stock is not in any smallcase yet.

EXPLEOSOL Events

EXPLEOSOL Events

EXPLEOSOL Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

EXPLEOSOL Dividend Trend

No dividend trend available

EXPLEOSOL Upcoming Dividends

EXPLEOSOL Upcoming Dividends

No upcoming dividends are available

EXPLEOSOL Past Dividends

EXPLEOSOL Past Dividends

Cash Dividend

Ex DateEx DateJul 31, 2026

Final
Final | Div/Share: ₹110.00

Dividend/Share

110.00

Ex DateEx Date

Jul 31, 2026

Cash Dividend

Ex DateEx DateFeb 12, 2025

Interim
Interim | Div/Share: ₹50.00

Dividend/Share

50.00

Ex DateEx Date

Feb 12, 2025

Cash Dividend

Ex DateEx DateJul 14, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

5.00

Ex DateEx Date

Jul 14, 2023

Cash Dividend

Ex DateEx DateJul 19, 2018

Final
Final | Div/Share: ₹20.00

Dividend/Share

20.00

Ex DateEx Date

Jul 19, 2018

Cash Dividend

Ex DateEx DateNov 9, 2017

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

Nov 9, 2017

EXPLEOSOL Stock News & Opinions

EXPLEOSOL Stock News & Opinions

Corporate
Corporate
Rizwan Shaikhmohammed resigns from Expleo Solutions Ltd., effective August 31, 2026

Expleo Solutions Ltd. announced that Rizwan Shaikhmohammed has resigned from his position as Director – Sales, USA, Key Managerial Personnel, and Senior Management Personnel, effective August 31, 2026, due to personal reasons.

1 month agoCapital Market - Live
Earnings
Earnings
Expleo Solutions Ltd consolidated sales up 1.84% on year in Q2FY2026

Expleo Solutions Ltd share price slipped 0.13% to Rs 821.05 after the company's net profit fell 17.97% to Rs 34.18 crore, while revenue from operations slightly gained 1.84% to Rs 291.55 crore in Q2FY26 over Q1FY26. The market capitalization of IT Enabled Services industry group stocks on BSE stood at Rs 2.4 lakh crore, slipping 0.57%. It has improved by 1.30% over last one week and rallied by 18.49% in last one month while the market capitalization of Expleo Solutions Ltd has softened by 1.58% and 7.13% in the same period respectively. Profit before tax (PBT) of Expleo Solutions Ltd stood at Rs 44.24 crore in Q2 FY26, expanding by 55.99% year-on-year, and retreating 13.05% quarter-on-quarter. EBITDA came in at Rs 35 crore, rallying 55.56% YoY and surging by 17.44% sequentially. Total expenses grew marginally by 1.45% to Rs 253.07 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 3.12 crore, slumping by 27.27% YoY, while employee benefits expense was at Rs 183.54 crore, registering a marginal contraction of 0.10% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 8.11% to Rs 1107.96 crore, while net profit jumped 20.09% to Rs 123.98 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 13749% to Rs 132.08 crore, and PBT registered a growth of 16.76% to Rs 162.57 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 119.47 crore in FY26, as against Rs 179.42 crore in FY25. Expleo Solutions Ltd crashed 27.48% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.05% during the same period.

1 month agoCapital Market - Live
Corporate
Corporate
Expleo Solutions Ltd. to review quarterly financial results at a board meeting

Expleo Solutions Ltd. will hold a board meeting on August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

1 month agoCapital Market - Live
Spotlight
Spotlight
Expleo Solutions Ltd leads losers in 'B' group

Asian Granito India Ltd, NRB Industrial Bearings Ltd, Signpost India Ltd and TV Vision Ltd are among the other losers in the BSE's 'B' group today, 31 July 2026.Expleo Solutions Ltd lost 11.57% to Rs 803 at 14:33 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 12419 shares were traded on the counter so far as against the average daily volumes of 6523 shares in the past one month.Asian Granito India Ltd crashed 9.56% to Rs 54.94. The stock was the second biggest loser in 'B' group.On the BSE, 10.25 lakh shares were traded on the counter so far as against the average daily volumes of 6.22 lakh shares in the past one month.NRB Industrial Bearings Ltd tumbled 7.65% to Rs 33.19. The stock was the third biggest loser in 'B' group.On the BSE, 1024 shares were traded on the counter so far as against the average daily volumes of 4023 shares in the past one month.Signpost India Ltd dropped 7.58% to Rs 287.7. The stock was the fourth biggest loser in 'B' group.On the BSE, 14103 shares were traded on the counter so far as against the average daily volumes of 39045 shares in the past one month.TV Vision Ltd plummeted 6.95% to Rs 4.55. The stock was the fifth biggest loser in 'B' group.On the BSE, 1098 shares were traded on the counter so far as against the average daily volumes of 3884 shares in the past one month.

1 month agoCapital Market - Live
Corporate
Corporate
Report highlights gaps in Indian operations' ethical business practices and stakeholder rights

A recent Business Responsibility Report reveals significant gaps in a company’s commitment to ethical and responsible business practices, according to a review of the document. The report, which focuses solely on Indian operations and excludes overseas branches, details affiliations with industry bodies like NASSCOM and CII, and outlines mechanisms for community grievance redressal. However, critical sections addressing due process, ethical business practices, stakeholder rights, legal compliance, human rights, and public policy engagement were notably absent. While the report mentions a cybersecurity policy and data privacy measures, the policy link is inaccessible externally, raising transparency concerns. The report also states that social impact assessments and rehabilitation/resettlement initiatives were “not applicable,” prompting questions about the company’s proactive efforts in inclusive growth and equitable development.

1 month agoCapital Market - Live
Corporate
Corporate
Board of Expleo Solutions recommends final dividend

Expleo Solutions announced that the Board of Directors of the Company at its meeting held on 28 July 2026, inter alia, have recommended the final dividend of Rs 110 per equity Share (i.e. 1100%) , subject to the approval of the shareholders.

1 month agoCapital Market - Live
Spotlight
Spotlight
Expleo Solutions Ltd Surges 15.34%, BSE Information Technology index Gains 2.07%

Expleo Solutions Ltd gained 15.34% today to trade at Rs 931.95. The BSE Information Technology index is up 2.07% to quote at 29821.68. The index is up 13.08 % over last one month. Among the other constituents of the index, Tanla Platforms Ltd increased 4.48% and Infosys Ltd added 3.75% on the day. The BSE Information Technology index went down 14.61 % over last one year compared to the 4.81% fall in benchmark SENSEX. Expleo Solutions Ltd has added 15.57% over last one month compared to 13.08% gain in BSE Information Technology index and 0.91% rise in the SENSEX. On the BSE, 10693 shares were traded in the counter so far compared with average daily volumes of 1631 shares in the past one month. The stock hit a record high of Rs 1299.95 on 29 Jul 2025. The stock hit a 52-week low of Rs 644.1 on 30 Mar 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Corporate
Expleo Solutions revises board meeting date

Expleo Solutions has revised the meeting of the Board of Directors which was scheduled to be held on 27 July 2026. The meeting will now be held on 28 July 2026.

1 month agoCapital Market - Live
Corporate
Corporate
Expleo Solutions to consider Dividend

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 27 July 2026.

1 month agoCapital Market - Live
Corporate
Corporate
Expleo Solutions schedules AGM

Expleo Solutions announced that the Annual General Meeting(AGM) of the company will be held on 26 August 2026.

2 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of EXPLEOSOL as on 21st September 2026 is ₹883.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Expleo Solutions Ltd (EXPLEOSOL) share are
    • Past 1 week: 0.22%
    • Past 1 month: -2.55%
    • Past 3 months: 5.90%
    • Past 6 months: 17.16%
    • Past 1 year: -16.43%
    • Past 3 years: -38.30%
    • Past 5 years: -16.78%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Expleo Solutions Ltd (EXPLEOSOL) is ₹1368.76 Cr as of 21st September 2026.

  4. The 52-week high of Expleo Solutions Ltd (EXPLEOSOL) is ₹1175.10 and the 52-week low is ₹640.

  5. The P/E (price-to-earnings) ratio of Expleo Solutions Ltd (EXPLEOSOL) is 11.04. The P/B (price-to-book) ratio is 1.76.

  6. Expleo Solutions Ltd (EXPLEOSOL) belongs to the Information Technology sector & Software Services sub-sector.

  7. You can directly buy Expleo Solutions Ltd (EXPLEOSOL) shares on Tickertape. Simply sign up, connect your demat account and place your order.